Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew P Cope

Showing results (111-120 of 133) with videos related to

Pageof 14
Sort By:
Nature Communications|February 1, 2019
The cholesterol biosynthesis pathway regulates IL-10 expression in human Th1 cellsEsperanza Perucha, Rossella Melchiotti, Jack A Bibby, et al.
BMJ Open|March 3, 2026
Pragmatic, open-label, multicentre, randomised controlled trial to guide initial therapy for immune checkpoint inhibitor-induced inflammatory arthritis comparing standard of care (prednisolone) to adalimumab without glucocorticoids: REACT trial protocolBenjamin A Fisher, Anna Rowe, Chris Hodson, et al.
The Lancet. Rheumatology|November 15, 2021
Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort studySatveer K Mahil, Katie Bechman, Antony Raharja, et al.
Plos One|October 10, 2019
Genetic associations with radiological damage in rheumatoid arthritis: Meta-analysis of seven genome-wide association studies of 2,775 casesMatthew Traylor, Rachel Knevel, Jing Cui, et al.
The Lancet. Rheumatology|June 30, 2026
Trends in autoimmune rheumatic disease diagnoses before and after the COVID-19 pandemic in England: a population-based cohort study using OpenSAFELYMark D Russell, Andrea Schaffer, Zijing Yang, et al.
The Lancet. Rheumatology|July 14, 2021
The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort studySatveer K Mahil, Katie Bechman, Antony Raharja, et al.
BMJ (Clinical Research Ed.)|January 21, 2026
Time trends in newly recorded diagnoses of 19 long term conditions before, during, and after the covid-19 pandemic: population based cohort study in England using OpenSAFELYMark D Russell, Andrea Schaffer, Katie Bechman, et al.
European Journal of Immunology|May 17, 2013
CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL-17 in a STAT3-dependent mannerBehdad Afzali, Peter J Mitchell, Francis C Edozie, et al.
Annals of the Rheumatic Diseases|August 7, 2021
EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritisKulveer Mankia, Heidi J Siddle, Andreas Kerschbaumer, et al.
Annals of the Rheumatic Diseases|June 9, 2022
Interferon-α-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogrammingFaye A H Cooles, Jessica Tarn, Dennis W Lendrem, et al.
Pageof 14

Showing results (111-120 of 133) with videos related to

Sort By:
Pageof 14
Nature Communications|February 1, 2019
The cholesterol biosynthesis pathway regulates IL-10 expression in human Th1 cellsEsperanza Perucha, Rossella Melchiotti, Jack A Bibby, et al.
BMJ Open|March 3, 2026
Pragmatic, open-label, multicentre, randomised controlled trial to guide initial therapy for immune checkpoint inhibitor-induced inflammatory arthritis comparing standard of care (prednisolone) to adalimumab without glucocorticoids: REACT trial protocolBenjamin A Fisher, Anna Rowe, Chris Hodson, et al.
The Lancet. Rheumatology|November 15, 2021
Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort studySatveer K Mahil, Katie Bechman, Antony Raharja, et al.
Plos One|October 10, 2019
Genetic associations with radiological damage in rheumatoid arthritis: Meta-analysis of seven genome-wide association studies of 2,775 casesMatthew Traylor, Rachel Knevel, Jing Cui, et al.
The Lancet. Rheumatology|June 30, 2026
Trends in autoimmune rheumatic disease diagnoses before and after the COVID-19 pandemic in England: a population-based cohort study using OpenSAFELYMark D Russell, Andrea Schaffer, Zijing Yang, et al.
The Lancet. Rheumatology|July 14, 2021
The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort studySatveer K Mahil, Katie Bechman, Antony Raharja, et al.
BMJ (Clinical Research Ed.)|January 21, 2026
Time trends in newly recorded diagnoses of 19 long term conditions before, during, and after the covid-19 pandemic: population based cohort study in England using OpenSAFELYMark D Russell, Andrea Schaffer, Katie Bechman, et al.
European Journal of Immunology|May 17, 2013
CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL-17 in a STAT3-dependent mannerBehdad Afzali, Peter J Mitchell, Francis C Edozie, et al.
Annals of the Rheumatic Diseases|August 7, 2021
EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritisKulveer Mankia, Heidi J Siddle, Andreas Kerschbaumer, et al.
Annals of the Rheumatic Diseases|June 9, 2022
Interferon-α-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogrammingFaye A H Cooles, Jessica Tarn, Dennis W Lendrem, et al.
Pageof 14